Skip to content
10-Q

Quarterly Report

Miromatrix Medical Inc.

0001558370-23-019009

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 9, 2023 27.42M sh
Shares Diluted Q3 2023 · Sep 30, 2023 27.31M sh
Shares Diluted Q3 2023 · Sep 30, 2023 25.71M sh
Shares Diluted Q3 2023 · Sep 30, 2022 20.9M sh
Shares Diluted Q3 2023 · Sep 30, 2022 20.66M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$18.26M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$20.63M
Long Term Debt Q3 2023 · Sep 30, 2023 $386K
Long Term Debt Q3 2023 · Dec 31, 2022 $386K
Cash And Equivalents Q3 2023 · Sep 30, 2023 $6.12M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $5.21M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $5.54M
Stockholders Equity Q3 2023 · Sep 30, 2023 $15.54M
Stockholders Equity Q3 2023 · Jun 30, 2023 $21.55M
Stockholders Equity Q3 2023 · Dec 31, 2022 $26.11M
Stockholders Equity Q3 2023 · Sep 30, 2022 $32.74M
Stockholders Equity Q3 2023 · Jun 30, 2022 $40.01M
Stockholders Equity Q3 2023 · Dec 31, 2021 $54.13M
Current Liabilities Q3 2023 · Sep 30, 2023 $4.97M
Current Liabilities Q3 2023 · Dec 31, 2022 $4.95M
Total Liabilities Q3 2023 · Sep 30, 2023 $7.88M
Total Liabilities Q3 2023 · Dec 31, 2022 $8.66M
Current Assets Q3 2023 · Sep 30, 2023 $17.19M
Current Assets Q3 2023 · Dec 31, 2022 $27.31M
Total Assets Q3 2023 · Sep 30, 2023 $23.42M
Total Assets Q3 2023 · Dec 31, 2022 $34.76M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.24
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.80
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.37
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.11
Eps Basic Q3 2023 · Sep 30, 2023 −$0.24
Eps Basic Q3 2023 · Sep 30, 2023 −$0.80
Eps Basic Q3 2023 · Sep 30, 2022 −$0.37
Eps Basic Q3 2023 · Sep 30, 2022 −$1.11
Sga Expense Q3 2023 · Sep 30, 2023 $2.14M
Sga Expense Q3 2023 · Sep 30, 2023 $6.78M
Sga Expense Q3 2023 · Sep 30, 2022 $2.05M
Sga Expense Q3 2023 · Sep 30, 2022 $6.51M
Rd Expense Q3 2023 · Sep 30, 2023 $3.51M
Rd Expense Q3 2023 · Sep 30, 2023 $11.52M
Rd Expense Q3 2023 · Sep 30, 2022 $4.57M
Rd Expense Q3 2023 · Sep 30, 2022 $13.57M
Net Income Q3 2023 · Sep 30, 2023 −$6.45M
Net Income Q3 2023 · Sep 30, 2023 −$20.46M
Net Income Q3 2023 · Sep 30, 2022 −$7.63M
Net Income Q3 2023 · Sep 30, 2022 −$23.01M
Operating Income Q3 2023 · Sep 30, 2023 −$6.64M
Operating Income Q3 2023 · Sep 30, 2023 −$21.42M
Operating Income Q3 2023 · Sep 30, 2022 −$7.76M
Operating Income Q3 2023 · Sep 30, 2022 −$23.18M
Gross Profit Q3 2023 · Sep 30, 2023 −$113.82K
Gross Profit Q3 2023 · Sep 30, 2023 −$347.33K
Gross Profit Q3 2023 · Sep 30, 2022 −$112.61K
Gross Profit Q3 2023 · Sep 30, 2022 −$351.89K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $125K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $375K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $125K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $375K
Revenue Q3 2023 · Sep 30, 2023 $11.18K
Revenue Q3 2023 · Sep 30, 2023 $27.67K
Revenue Q3 2023 · Sep 30, 2022 $12.4K
Revenue Q3 2023 · Sep 30, 2022 $23.12K